82 related articles for article (PubMed ID: 17581410)
1. pRb, p16, and cyclin D1 in small cell carcinoma of the uterine cervix.
Horn LC; Hauptmann S; Leo C
Int J Gynecol Pathol; 2007 Jul; 26(3):269. PubMed ID: 17581410
[No Abstract] [Full Text] [Related]
2. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16 and lack of pRB in primary small cell lung cancer.
Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
Lerma E; Esteller M; Herman JG; Prat J
Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
[TBL] [Abstract][Full Text] [Related]
5. p16, p14, p53, and Cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix by Horn et al.
Herrington CS
Int J Gynecol Pathol; 2006 Oct; 25(4):408. PubMed ID: 16990721
[No Abstract] [Full Text] [Related]
6. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
7. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
[TBL] [Abstract][Full Text] [Related]
8. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma.
Liu T; Zhu E; Wang L; Okada T; Yamaguchi A; Okada N
Hum Pathol; 2005 Sep; 36(9):962-70. PubMed ID: 16153458
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic importance of altered expression of cell cycle regulators in lung cancer].
Akita H
Nihon Rinsho; 2002 May; 60 Suppl 5():267-71. PubMed ID: 12101670
[No Abstract] [Full Text] [Related]
11. Alterations found in pl6/Rb/cyclin D1 pathway in the dysplastic and malignant cervical epithelium.
Vijayalakshmi N; Selvaluxmi G; Majhi U; Rajkumar T
Oncol Res; 2007; 16(11):527-33. PubMed ID: 18306932
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
Tsai H; Morais CL; Alshalalfa M; Tan HL; Haddad Z; Hicks J; Gupta N; Epstein JI; Netto GJ; Isaacs WB; Luo J; Mehra R; Vessella RL; Karnes RJ; Schaeffer EM; Davicioni E; De Marzo AM; Lotan TL
Clin Cancer Res; 2015 Dec; 21(24):5619-29. PubMed ID: 26246306
[TBL] [Abstract][Full Text] [Related]
14. p16, retinoblastoma (pRb), and cyclin D1 protein expression in human endometriotic and adenomyotic lesions.
Goumenou AG; Matalliotakis IM; Tzardi M; Fragouli IG; Mahutte NG; Arici A
Fertil Steril; 2006 Apr; 85 Suppl 1():1204-7. PubMed ID: 16616093
[TBL] [Abstract][Full Text] [Related]
15. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors.
Li AF; Li AC; Tsay SH; Li WY; Liang WY; Chen JY
Am J Clin Pathol; 2008 Oct; 130(4):535-42. PubMed ID: 18794045
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the retinoblastoma and p16 pathway correlate with promoter methylation in malignant fibrous histiocytomas.
Brinck U; Schlott T; Störber S; Stachura J; Bortkiewicz P; Nagel WD; Hasse FM; Cordon-Cardo C; Fischer G; Korabiowska M
Anticancer Res; 2006; 26(5A):3461-5. PubMed ID: 17094467
[TBL] [Abstract][Full Text] [Related]
18. Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker.
Masoudi H; Van Niekerk DJ; Gilks CB; Cheang M; Bilek K; Fischer U; Ehlen T; Miller D; Horn LC
Histopathology; 2006 Nov; 49(5):542-5. PubMed ID: 17064304
[No Abstract] [Full Text] [Related]
19. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
Park HW; Song SY; Lee TJ; Jeong D; Lee TY
Oncol Rep; 2007 Jul; 18(1):267-72. PubMed ID: 17549378
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of cyclin D1 and p16 in hypopharyngeal squamous cell carcinoma and their clinical significance].
Fu Z; Pan X; Lei D; Liu D; Liu W; Liu C; Wang R; Ye P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(9):406-9. PubMed ID: 17634024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
